Aug. 7, 2020 – The Executive Order signed Aug. 6 by President Donald J. Trump to increase production of essential medical supplies in the United States is raising a lot of eyebrows in the biopharmaceutical industry, largely because pivoting to such a model will not be easy and may end up costing more, both in […]
Read more